Abiopharma

Viper Energy, Inc., A Subsidiary Of Diamondback Energy, Inc., Reports Second Quarter 2026 Financial And Operating Results; Increases Base Dividend

Diamondback Energy, Inc. Announces Second Quarter 2026 Financial and Operating Results

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Capital Southwest Announces Financial Results for First Fiscal Quarter Ended June 30, 2026

argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026

United Fire Group, Inc. reports second quarter 2026 results

Letter to Stockholders Issued by Diamondback Energy, Inc.

Keros Therapeutics Reports Second Quarter 2026 Financial Results

Stoke Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Updates

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

📋 Jover Placid (Executive VP, Chief HR Officer) plans to sell 13K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD (at $34.88 each, total $447K) Filed: Aug 03, 2026 | ID: 000273

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule

AlTi Global, Inc. to Announce Second Quarter 2026 Financial Results

📋 Brogan Ptacin (Director) plans to sell 9K shares of Byline Bancorp, Inc. (at $39.64 each, total $375K) Filed: Aug 03, 2026 | ID: 051781